NCT00972933
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of Pittsburgh Medical Center/University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
2,209 public trials
376 recruiting studies
Melanoma trial results
Completed
Moletest Clinical Study in Scotland
NCT02196246
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- NHS Lanarkshire R&D Airdrie, United Kingdom
NCT01711684
- Conditions
- Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
- Locations
-
- The Rockefeller University New York, United States
NCT00667082
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +40 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- The Queen Elizabeth Hospital Woodville South, South Australia, Australia
- Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia
NCT00387751
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
- Locations
-
- Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States
NCT00526617
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +41 more
- Locations
-
Not specified
NCT00019682
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Kaiser Permanente Medical Center Riverside, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
NCT01954043
- Conditions
- Cancer, Melanoma, Neoplasms, +10 more
- Locations
-
- GSK Investigational Site Goodyear, Arizona, United States
- GSK Investigational Site Dallas, Texas, United States
- GSK Investigational Site Tacoma, Washington, United States
- GSK Investigational Site Heidelberg, Victoria, Australia
Completed
Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies
NCT02441465
- Conditions
- Malignant Melanoma, Cancer, Melanoma, Neoplasms, +10 more
- Locations
-
- Magyar Honvedseg Egeszsegugyi Kozpont Budapest, Hungary
NCT01767454
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site St Louis, Missouri, United States